ClinicalTrials.gov
public full text
Public Domain
Understanding Clinician Utilization of Corus CAD (Age/Sex/Gene Expression Score - ASGES) in Clinical Decision Making
The purpose of this study is to understand the use of Corus CAD also known as Age/Sex/Gene Expression score (ASGES) in the clinical decision making process of patients who underwent the evaluation of chest pain or anginal equivalent symptoms. Specifically, to better understand whether the use of the assay in clinical decision making resulted in changes in noninvasive diagnostic test ordering or diagnostic yield of additional tests ordered and/or invasive angiography.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- ProspEctive First Evaluation in Chest Pain Trial#969761
- COvid-19 LongitUdinal Multiethnic BioImaging Assessment of CARDiovascular Sequelae Registry#846442
- Less Invasive Detection and Treatment of Very Early Coronary Artery Disease in Patients With Diabetes Mellitus#1164970
- Contrast Echocardiography in Non-ST Elevation Myocardial Infarction#845951
- Identification of Genetic Factors Determining Disease Course in the New Type of Coronavirus Infection, COVID-19#994495
Record · ID 803315
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive